World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
136
Citations
62858
World Ranking
188
National Ranking
122

Medicine

D-Index
136
Citations
62866
World Ranking
1991
National Ranking
1129

Soldano Ferrone publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Soldano Ferrone sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 69 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 1,235 publications — 100th percentile

100% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Soldano Ferrone D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Soldano Ferrone sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 163 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 136 D-Index — 96th percentile

96% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

Soldano Ferrone was affiliated with Harvard University in the United States. Their research primarily focused on medicine, with significant contributions in immunology and microbiology. The subfields where they published extensively included oncology, immunology, molecular biology, cancer research, and biomedical engineering.

Their scientific work concentrated on several main topics, particularly immunotherapy and immune responses, CAR-T cell therapy research, and cancer immunotherapy and biomarkers. Other notable topics included immune cell function and interaction, T-cell and B-cell immunology, cancer cells and metastasis, and extracellular vesicles in disease.

Soldano Ferrone published numerous papers in prominent venues, often collaborating with frequent co-authors such as Xinhui Wang, Cristina R. Ferrone, Giulia Cattaneo, Gianpietro Dotti, and Filippos Kontos. Their common publication venues featured:

  • Cancer Research
  • Clinical Cancer Research
  • Journal of Translational Medicine
  • Journal of the American College of Surgeons
  • Regular and Young Investigator Award Abstracts

Among their recent publications were works covering various aspects of immunotherapy and cancer research. Some of these included:

  • "B7-H3: An Attractive Target for Antibody-based Immunotherapy" (2020) published in Clinical Cancer Research
  • "Melanoma cell-derived exosomes in plasma of melanoma patients suppress functions of immune effector cells" (2020) published in Scientific Reports
  • "IL15 Stimulation with TIGIT Blockade Reverses CD155-mediated NK-Cell Dysfunction in Melanoma" (2020) published in Clinical Cancer Research
  • "CAR T Cell-Based Immunotherapy for the Treatment of Glioblastoma" (2021) published in Frontiers in Neuroscience
  • "The SPPL3-Defined Glycosphingolipid Repertoire Orchestrates HLA Class I-Mediated Immune Responses" (2020) published in Immunity

Ferrone's extensive research output contributed primarily to the understanding of immune mechanisms in cancer, immunotherapy approaches, and advanced cell-based therapies such as CAR-T cells. Their work was widely cited and embedded within the broader community of translational medicine and cancer immunology.

Best Publications

  • Escape of human solid tumors from T-cell recognition: molecular mechanisms and functional significance.

    Francesco M. Marincola;Elizabeth M. Jaffee;Daniel J. Hicklin;Soldano Ferrone

  • Major Histocompatibility Complex Class I-related Chain A and UL16-Binding Protein Expression on Tumor Cell Lines of Different Histotypes Analysis of Tumor Susceptibility to NKG2D-dependent Natural Killer Cell Cytotoxicity

    Daniela Pende;Paola Rivera;Stefania Marcenaro;Chien Chung Chang

  • Impaired HLA Class I Antigen Processing and Presentation as a Mechanism of Acquired Resistance to Immune Checkpoint Inhibitors in Lung Cancer

    Scott Gettinger;Jungmin Choi;Katherine Hastings;Anna Truini

  • Loss of HLA class I antigens by melanoma cells: molecular mechanisms, functional significance and clinical relevance.

    Soldano Ferrone;Francesco M. Marincola

  • Antigen-processing machinery breakdown and tumor growth.

    Barbara Seliger;Markus J Maeurer;Soldano Ferrone

  • Immunotherapy of Cancer in 2012

    John M. Kirkwood;Lisa H. Butterfield;Ahmad A. Tarhini;Hassane Zarour

  • Enhancement of sheep red blood cell human lymphocyte rosette formation by the sulfhydryl compound 2-amino ethylisothiouronium bromide.

    M.A. Pellegrino;S. Ferrone;M.P. Dierich;R.A. Reisfeld

  • HLA class I antigen downregulation in human cancers: T-cell immunotherapy revives an old story

    Daniel J Hicklin;Francesco M Marincola;Soldano Ferrone

  • HLA antigen changes in malignant cells: epigenetic mechanisms and biologic significance

    Michael Campoli;Soldano Ferrone

  • Immune-induced epithelial to mesenchymal transition in vivo generates breast cancer stem cells

    Marta Santisteban;Jennifer M. Reiman;Michael K. Asiedu;Marshall D. Behrens

  • Antitumor Responses in the Absence of Toxicity in Solid Tumors by Targeting B7-H3 via Chimeric Antigen Receptor T Cells

    Hongwei Du;Koichi Hirabayashi;Sarah Ahn;Nancy Porterfield Kren

  • Lack of HLA class I antigen expression by cultured melanoma cells FO-1 due to a defect in B2m gene expression.

    C. M. D'urso;Zhigang Wang;Yan Cao;R. Tatake

  • Tumor Antigen–Targeted, Monoclonal Antibody–Based Immunotherapy: Clinical Response, Cellular Immunity, and Immunoescape

    Robert L. Ferris;Elizabeth M. Jaffee;Soldano Ferrone

  • Radiation-induced immunogenic modulation of tumor enhances antigen processing and calreticulin exposure, resulting in enhanced T-cell killing

    Sofia R. Gameiro;Momodou L. Jammeh;Max M. Wattenberg;Kwong Y. Tsang

  • Distribution and molecular characterization of a cell-surface and a cytoplasmic antigen detectable in human melanoma cells with monoclonal antibodies

    Barry S. Wilson;Kohzoh Imai;Pier G. Natali;Soldano Ferrone

  • NCRs and DNAM-1 mediate NK cell recognition and lysis of human and mouse melanoma cell lines in vitro and in vivo

    Tadepally Lakshmikanth;Shannon Burke;Talib Hassan Ali;Silvia Kimpfler

  • Soluble HLA-A,-B,-C and -G molecules induce apoptosis in T and NK CD8+ cells and inhibit cytotoxic T cell activity through CD8 ligation.

    Paola Contini;Massimo Ghio;Alessandro Poggi;Gilberto Filaci

  • Monoclonal antibodies for cancer immunotherapy

    Louis M Weiner;Madhav V Dhodapkar;Madhav V Dhodapkar;Soldano Ferrone

  • Immunobiological Characterization of Cancer Stem Cells Isolated from Glioblastoma Patients

    Tiziano Di Tomaso;Stefania Mazzoleni;Ena Wang;Gloria Sovena

  • Differential expression of intercellular adhesion molecule 1 in primary and metastatic melanoma lesions.

    Piergiorgio Natali;Maria R. Nicotra;Renato Cavaliere;Aldo Bigotti

  • Human high molecular weight melanoma-associated antigen (HMW-MAA) mimicry by mouse anti-idiotypic monoclonal antibody MK2-23: induction of humoral anti-HMW-MAA immunity and prolongation of survival in patients with stage IV melanoma

    Abraham Mittelman;Zhi Jian Chen;Hong Yang;George Y. Wong

Frequent Co-Authors

Ralph A. Reisfeld
Ralph A. Reisfeld Scripps Research Institute
Cristina R. Ferrone
Cristina R. Ferrone Harvard University
Robert L. Ferris
Robert L. Ferris University of Pittsburgh
Francesco Indiveri
Francesco Indiveri University of Genoa
Vito Quaranta
Vito Quaranta Vanderbilt University
Patrizio Giacomini
Patrizio Giacomini Sapienza University of Rome
Theresa L. Whiteside
Theresa L. Whiteside University of Pittsburgh
Pier Giorgio Natali
Pier Giorgio Natali PharmaMab S.r.l.
Gianpietro Dotti
Gianpietro Dotti University of North Carolina at Chapel Hill
Francesco M. Marincola
Francesco M. Marincola National Institutes of Health

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For students interested in Immunology, pursuing related online degrees can open doors to rewarding healthcare careers. Specialized nursing programs often complement immunological expertise, particularly in mental health and acute care settings. Exploring pmhnp programs online with best clinical placement will help aspiring Psychiatric Mental Health Nurse Practitioners gain practical experience while studying remotely.

Cost is another important factor. Many students seek affordable options without compromising quality, making the list of cheapest pmhnp programs online a valuable resource when planning their education paths in related fields.

Career advancement often involves understanding salary trends and specialties. For instance, analyzing highest paid dnp specialties can inform decisions about which Doctor of Nursing Practice track aligns best with one’s goals and market demand.

Additionally, transitioning between nursing roles is common. Programs like acute care nurse practitioner programs support seamless movement from Family Nurse Practitioner to Acute Care NP, expanding clinical skillsets relevant to immunology-related healthcare environments.

Best Scientists Citing Soldano Ferrone

Recently Published Articles